Giuseppe Avvisati - Concepedia

Author

Giuseppe Avvisati

Also Known As

Anwarul Islam, Avvisati G, Avvisati, Giuseppe, G AVVISATI, G Avvisati, G. AVVISATI, G. Avvisati, G. avvisati, G., Avvisati, GIUSEPPE AVVISATI

334

Publications

15.8K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome Università Campus Bio-Medico University of Rome Tor Vergata University of Bari Aldo Moro Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

About

Giuseppe Avvisati is an author at Sapienza University of Rome specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	44	3.2K
2	Health Sciences	9	9	979
3	Public Health	2	2	32
4	Natural Sciences	1	1	64
5	Biomedical Engineering	1	1	55

Giuseppe Avvisati

126

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, New England Journal of Medicine	2013	1.6K
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial Andrés JM Ferreri, Michele Reni, Marco Foppoli, The Lancet Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaMedicinePrimary Cns Lymphoma	2009	656
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Miguel Á. Sanz, Francesco Lo‐Coco, Giuseppe Avvisati, PubMed	2000	632
The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid Leukemia Paolo Rebulla, Guido Finazzi, Francesca Marangoni, New England Journal of Medicine	1997	583
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Franco Mandelli, Daniela Diverio, Giuseppe Avvisati, PubMed	1997	474
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials Stefano Pasquali, J D Maqueo, Jorge Espino Vela, Oxford University Research Archive (ORA) (University of Oxford) Hematological MalignancyOncologyMetronomic TherapyImmunologyRandomized Trials	1998	473
Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy Franco Mandelli, Giuseppe Avvisati, Sergio Amadori, New England Journal of Medicine	1990	385
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, Journal of Clinical Oncology	2016	375
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Daniele Santini, Bruno Vincenzi, Giordano Dicuonzo, PubMed	2003	356
Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells Wenlin Shao, Mirco Fanelli, Fabiana Fosca Ferrara, JNCI Journal of the National Cancer Institute	1998	352

Page 1